About usOur ApproachOur PipelinePatientsInvestorsCareers

You are leaving Spyre

If you would like to proceed, click the link to continue.
https://twitter.com/

Go back
Continue
Spyre is not responsible for content on external websites.
Please review their Privacy Policy.
Back to People
Laurie Stelzer

Laurie Stelzer

Laurie Stelzer is a veteran Chief Financial Officer and board director, most recently serving as CFO at Kailera Therapeutics a clinical-stage biopharmaceutical company focused on the treatment of obesity and related conditions. She currently serves on the board of Siona Therapeutics and Spyre Therapeutics, Inc. Laurie has over 25 years of finance and business development leadership experience in the biopharmaceutical industry. She has held leadership roles in finance, treasury, global accounting, business development, project management, and site operations for a range of biopharmaceutical companies including as CFO of Orna Therapeutics, Mirati Therapeutics, Inc., Arena Pharmaceuticals, Inc., and Halozyme Therapeutics, Inc. She also held senior management roles at Shire Plc and Amgen, Inc., and previously served on the board of Surface Oncology, Inc. and Longboard Pharmaceuticals. Laurie earned a B.S. in Accounting from Arizona State University and an M.B.A. from University of California, Los Angeles, Anderson School of Management.

‍